Company Filing History:
Years Active: 2013
Title: Fernanda Staquicini: Innovator in Cancer Therapeutics
Introduction
Fernanda Staquicini is a prominent inventor based in Houston, Texas. She has made significant contributions to the field of cancer therapeutics, particularly through her innovative work on MUC18 targeting peptides. Her research aims to improve treatment options for patients suffering from melanoma and leukemia.
Latest Patents
Fernanda holds 1 patent for her invention related to MUC18 targeting peptides. These peptides are designed to therapeutically target B-I lymphocytes, thereby reducing their influence on the metastatic potential of melanoma cells. Additionally, they can be utilized to target cancerous cells, including specific melanoma and leukemia cells. The MUC18 targeting peptides may be incorporated into various constructs, such as fusion constructs, imaging constructs, and therapeutic constructs, which can be used for diagnosing or treating cancer.
Career Highlights
Fernanda is affiliated with the University of Texas System, where she continues her research and development in cancer therapeutics. Her work has garnered attention for its potential to revolutionize treatment methodologies in oncology.
Collaborations
Fernanda collaborates with esteemed colleagues, including Renata Pasqualini and Wadih Arap, who contribute to her research endeavors and enhance the impact of her innovations.
Conclusion
Fernanda Staquicini is a trailblazer in the field of cancer research, with her MUC18 targeting peptides offering promising avenues for therapeutic intervention. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of innovation in medical science.